 |
 |
 |
Country |
|
|
Pharmaceuticals in Mexico
Publication Date January 2008
Publisher Datamonitor
Product Type Strategic Report
Pages 36
ISBN Number not applicable
Product Code DAT853
|
|
|
Summary
Datamonitor's Pharmaceuticals in Mexico industry profile is an essential resource for top-level data and analysis covering the pharmaceuticals industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.
Scope
- Contains an executive summary and data on value, volume and/or segmentation
- Provides textual analysis of the industry's recent performance and future prospects
- Incorporates in-depth five forces competitive environment analysis and scorecards
- Includes a five-year forecast of the industry
- The leading companies are profiled with supporting key financial metrics
- Supported by the key macroeconomic and demographic data affecting the market
Highlights
- Detailed information is included on market size, measured by value and/or volume
- Five forces scorecards provide an accessible yet in depth view of the market's competitive landscape
- Market shares are covered by manufacturer or brand
Why you should buy this report
- Spot future trends and developments
- Inform your business decisions
- Add weight to presentations and marketing materials
- Save time carrying out entry-level research
Market Definition
The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2006 annual average exchange rates.
For the purpose of this report the Americas comprise Brazil, Canada, Mexico and the US.
|
Content
- Executive Summary
- Chapter1 Market Overview
- Market Definition
- Highlights
- Chapter2 Market Value
- Chapter3 Market Segmentation I
- Chapter4 Market Segmentation Ii
- Chapter5 Market Share
- Chapter6 Five Forces Analysis
- 6.1 Summary
- 6.2 Buyer Power
- 6.3 Supplier Power
- 6.4 New Entrants
- 6.5 Substitutes
- 6.6 Rivalry
- Chapter7 Leading Companies
- 7.1 Pfizer Inc
- 7.2 Glaxosmithkline Plc
- 7.3 Sanofi-Aventis
- 7.4 Eli Lilly And Company
- Chapter8 Market Forecasts
- 8.1 Market Value Forecast
- Chapter9 Macroeconomic Indicators
- Chapter10 Appendix
- 10.1 Methodology
- 10.2 Industry Associations
- 10.3 Related Datamonitor Research
- List Of Tables
- Table 1: Mexico Pharmaceuticals Market Value: $ Million, 2003-2007
- Table 2: Mexico Pharmaceuticals Market Segmentation I: % Share, By Value, 2007
- Table 3: Mexico Pharmaceuticals Market Segmentation Ii: % Share, By Value, 2007
- Table 4: Mexico Pharmaceuticals Market Share: % Share, By Value, 2007
- Table 5: Key Facts: Pfizer Inc
- Table 6: Key Financials: Pfizer Inc
- Table 7: Key Facts: Glaxosmithkline Plc
- Table 8: Key Financials: Glaxosmithkline Plc
- Table 9: Key Facts: Sanofi-Aventis
- Table 10: Key Financials: Sanofi-Aventis
- Table 11: Key Facts: Eli Lilly And Company
- Table 12: Key Financials: Eli Lilly And Company
- Table 13: Mexico Pharmaceuticals Market Value Forecast: $ Million, 2007-2012
- Table 14: Mexico Size Of Population (Million) , 2003-2007
- Table 15: Mexico Gdp (Constant 2000 Prices, $ Billion), 2003-2007
- Table 16: Mexico Inflation, 2003-2007
- Table 17: Mexico Exchange Rate, 2003
|
|
|